Experiences with

Lung cancer

Am I correct that when a patient becomes resistant to either enzalutamide or abiraterone, or has to stop due to arrhythmia one cannot be substitued for the other? Other than docetaxel (chemo) are there other commonly used treatments after enzalutamide or abiraterone resistance?

Looks like this new 3-month formulation of leuprolide mesylate could be a game-changer for men with advanced prostate cancer. You won't have to visit the doctor as often for your injections (I am on triptorelin myself). Just imagine, fellas: fewer needles, more fun! 😄 https://prostatewarriors.com

I have been off ADT for over two years. Testosterone was up to 324 last month, while my PSA has slowly gone up from undetectable to 9.06 during that same time. My recent PSMA shows uptake in the R sacrum sclerotic lesion concerning for metastasis, as the only site beyond the prostate. Dr. Kirschner

PSA is going up. 0.04 on 24th April, 0.27 on 25th July, 0.41 on 24th August and 1.68 today. I have been on Eligard since I was diagnosed with metastatic PCa in 2016 and my psa has been usually negligible. Have had radiation, chemotherapy (Docetaxel) and SBRT to 2 areas (T10 vertebrae & 6th rib) over

I was just told that I’ve been turned down for any active clinical trials. PC stopped responding to both Abiraterone and Xtandi so I will be starting Docetaxel tomorrow. Has anyone else been in this dilemma and still doing well? It’s

As beta emitter it is promising, but to me it sounds like it would not be easy to produce on location, but another arrow is always useful! :-) https://prostatewarriors.com/2024/10/31/phase-2-iodine-131-psma-radioligand-with-enzalutamide-shows-promise-in-arrow-trial-for-metastatic-castration-resistant-prostate-cancer-mcrpc

Dear All,Following on from everybody's wonderful advice and comments last year I just thought that maybe some people in the community might be wondering how things are panning out a year on from my Retzius-sparing RALP with frozen sections here on the other side of the pond. I would report that my last

Following day 13 of a 26-day adaptive SbRT program, my partner has developed significant pain in his lower back and thighs. The radiation is targeting his pelvic bed, with particular focus on his prostate and the one lymph node that lit up on PSMA PET. Has anyone else experienced this? If so, was there

Date Value Normal Range Oct 29, 2024 15.85ng/mLHigh < OR = 4.00 ng/mL Oct 10, 2024 6.79ng/mLHigh < OR = 4.00 ng/mL Aug 13, 2024 1.86ng/mL < OR = 4.00 ng/mL Jul 15, 2024 1.59ng/mL < OR = 4.00 ng/mL Jun 25, 2024 1.51ng/mL < OR = 4.00 ng/mL My question is there any reason to continue with

Once Orgovyx and Zytiga and Xtandi are no longer stopping my PSA from rising rapidly is there any point to continue taking them. My PSA is doubling every two weeks. It has gone from 0.67 to about 16 in two months. Poollover

Bicalutamide is supposed specifically to block metastatic cancer cells Testosterone receptors to starve them of their growth potential. Even so, testosterone has many additional functions, one of which is to produce and facilitate muscle growth and maintenance of the same. I have lost a lot of weight

Anyone using this for sleep and or fighting your cancer? Is it helpful in either regard? Apigenin and prostate cancer… https://pmc.ncbi.nlm.nih.gov/articles/PMC3983429/pdf/bgt316.pdf

Hi All, following a PSA of 4.2 and biopsy I was diagnosed as Gleason 3+4 T2cN0 (0/15) R0. I had an RP in Dec 2018 and was undetectable for 18 months before PSA slowly began to climb. In 2024 my PSA hit 0.2 and I had a PSMA that identified a small tumour by a clip from surgery in the prostate bed. May

Hello everyone! I have posted a couple of times before and appreciate how comforting and informative everyone is. I have an update on my dad's treatment progress and a question about rising PSA. Brief history: My 60 year old father was diagnosed with stage 4 prostate cancer that has spread to his

Hi everyone My father has been on Lupron for 3 years now but his PSA has started to rise (latest 3.7ng/ml). His T levels are 0.06ng/ml. Is Abiraterone likely to help arrest cancer spread if the T is already so low? I know that Prostate Cancer thrives on other androgens as well but I am assuming that

Summary Paragraph: The study examines testosterone recovery (TR) in prostate cancer patients undergoing androgen deprivation therapy (ADT) in conjunction with radiotherapy, as assessed across multiple randomized trials by the MARCAP Consortium. Variabilities in TR were identified based on ADT

I never did, though I was diagnosed in 2018. I did have a TURP, however, which was completely ineffective (the goal was freeing urination; didn't work). It occurred to me that most of the posters here probably had prostatectomies, which would make them far more concerned about rises in PSA. My PSA

[i]This MedPage article was the "Featured Study" on this recent ASCO Reading Room Article Series. The interview of first author Dr. Charles Nguyen spotlights the underutilization of bone modifying agents (BMAs) in mCRPCa patients found in their study. (Linked below.) It is probably safe to assume that

https://www.lapresse.ca/actualites/chroniques/2024-10-28/cancer-de-la-prostate/se-faire-tester-ou-pas. Large (est?) paper in Montréal about one of their own with PCa and what other men could or should do. In French but my link gave option of English translation. In my French reading it was a balanced

https://youtu.be/tn4QB5t4nGw Subscribe to our channel for expert advice, support, and real stories from the world's leading nonprofit for prostate cancer survivors. Stay informed and empowered—hit the subscribe link here: https://www.youtube.com/c/malecare?sub_confirmation=1 In this heartfelt interview